INVITRO AND INVIVO PRODUCTION OF CHEMOTACTIC INHIBITORS BY TUMOR-CELLS
- 1 January 1979
- journal article
- research article
- Vol. 94 (3), 603-614
Abstract
The ascites fluid or peritoneal washings of DBA/2 mice bearing the P815 mastocytoma contained a chemotactic factor inactivator (CFI) which inactivated the bacterial chemotactic factor and the chemotactic activity associated with the C3 [3rd complement component] and C5 fragments when assayed on rabbit neutrophils. The amount of CFI was proportional to the number of tumor cells in the peritoneal exudate. The inactivator was also found in tumor cell hemogenates and in culture fluid from tumor cells growing in vitro. The activity was heat-labile but was not affected by protease inhibitors. Its MW was greater than 50,000 daltons, based on Sephadex chromatography and sucrose density gradient ultracentrifugation studies. In C57BL/6 mice, which rejected the mastocytoma, CFI levels decreased in proportion to the decreasing numbers of tumor cells.This publication has 25 references indexed in Scilit:
- Serum-associated inhibition of leukotaxis in humans with cancerClinical Immunology and Immunopathology, 1978
- Chemotactic factor inactivators of human granulocytes.Journal of Clinical Investigation, 1977
- Inhibition of Leukocyte Chemotaxis by Homogenates of Tumor TissuesOncology, 1977
- TUMOR‐ASSOCIATED IMMUNOSUPPRESSIVE FACTORSAnnals of the New York Academy of Sciences, 1976
- An Inhibitor of Macrophage Chemotaxis Produced by NeoplasmsScience, 1976
- Antileukotactic properties of tumor cells.Journal of Clinical Investigation, 1975
- Chemotactic Factor Inactivator in Normal Human SerumJournal of Clinical Investigation, 1973
- Cooperation of Immune Lymphoid Cells with Macrophages in Tumour ImmunityNature, 1970
- Cellular and humoral immune responses to human urinary bladder carcinomasInternational Journal of Cancer, 1970
- Chemotaxis of polymorphonuclear leukocytesBiochemical Pharmacology, 1968